Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

Comparative Investigation of Internal Dosimetry Methodologies

Wencke Lehnert, Karl Schmidt, Sharok Kimiaei, Marcus Bronzel and Andreas Kluge
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 307;
Wencke Lehnert
2Image Core Lab ABX - CRO advanced pharmaceutical services GmbH Dresden Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl Schmidt
2Image Core Lab ABX - CRO advanced pharmaceutical services GmbH Dresden Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharok Kimiaei
2Image Core Lab ABX - CRO advanced pharmaceutical services GmbH Dresden Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus Bronzel
2Image Core Lab ABX - CRO advanced pharmaceutical services GmbH Dresden Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Kluge
1ABX - CRO advanced pharmaceutical services GmbH Dresden Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

307

Objectives The need for individual patient dosimetry is increasingly perceived as relevant for patient care and for the development of new therapeutic radiopharmaceuticals (2013/59/EURATOM). Different methodologies for dose calculation exist and their accuracy is an important factor in dosimetry. In this work we aimed (1) to investigate and validate voxel S dose calculation for patient-specific safety and tumor dosimetry and (2) to compare two dose calculation tools, the ICRP-endorsed IDAC 1.0 package, and OLINDA/EXM 1.1, commonly used for phantom-based safety dosimetry. All evaluations were performed using QDOSE, a comprehensive software solution allowing for direct comparison of different methodologies.

Methods Voxel S dose calculations were validated against the spherical model implemented in the OLINDA/EXM software using spherical objects of masses of 10, 50, 100 and 1000 g for the isotopes 177Lu, 90Y, 131I and 188Re using implemented or interpolated voxel S kernels depending on the voxel size of the images. For safety dosimetry, the software tools IDAC 1.0 and OLINDA/EXM 1.1, which are both based on the stylized Cristy-Eckerman phantom series, were compared for patient data acquired with 177Lu-Dotatoc.

Results The voxel S mean doses in spherical objects were in good agreement with the spherical model showing differences of -10.5 % to -12.6% for 177Lu, -4.5% to -10.5% for 90Y, -6.1% to -22% for 131I and -7.3% to -12.4% for 188Re. No differences between implemented and interpolated voxel S kernels were observed. Comparing IDAC 1.0 to OLINDA/EXM 1.1, the absorbed doses to all organs for 177Lu-Dotatoc were within 2%, except for the remainder body with a 4.8% and red marrow with a 31.6% difference when kidneys, spleen and remainder body were included as source organs. Adding red marrow as a source organ, the red marrow dose with IDAC 1.0 was lower than with OLINDA/EXM 1.1 with a maximum difference of -27.5% depending on the residence time ratio of remainder body to red marrow.

Conclusions Voxel S dose calculation using kernels based on EGSnrc allows for accurate tumor efficacy or patient-specific organ safety dosimetry. Differences between voxel S and spherical model are mostly related to improvements in radiation transport simulation in the Monte Carlo code EGSnrc (DOSXYZnrc) used for the voxel S generation compared to EGS4 and MCNP used for the spherical model. The differences between IDAC 1.0 and OLINDA/EXM 1.1 are of the same magnitude or lower than potential errors in dose calculation due to the difference between individual patients and the stylized reference phantom. They are related to a red marrow correction implemented in OLINDA/EXM while IDAC 1.0 follows MIRD and assumes only self-absorption for electrons. The successor IDAC 2.0 uses the ICRP reference phantom and will incorporate measured absorbed fractions for electrons and therefore surpass the previous limitations for more accurate dosimetry including for the red marrow.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparative Investigation of Internal Dosimetry Methodologies
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparative Investigation of Internal Dosimetry Methodologies
Wencke Lehnert, Karl Schmidt, Sharok Kimiaei, Marcus Bronzel, Andreas Kluge
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 307;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparative Investigation of Internal Dosimetry Methodologies
Wencke Lehnert, Karl Schmidt, Sharok Kimiaei, Marcus Bronzel, Andreas Kluge
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 307;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

Oncology: Basic, Translational & Therapy -> Technical Advances and Quantification [1]

  • Interventional nuclear imaging for SIRT - a phantom study
  • Ultralow dose CT attenuation correction for lung cancer PET/CT screening - a phantom evaluation study
  • 90Y PET/CT for dosimetry measurement and quantitative optimization in inoperable HCC patients treated by 90Y glass microspheres radioembolization
Show more Oncology: Basic, Translational & Therapy -> Technical Advances and Quantification [1]

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire